Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 12|pp. 5223–5232
The efficacy of adding hyperthermia to the treatment of advanced NSCLC patients based on the states of EGFR
Back to articleFigure 1(1 of 4)
100%
Figure 1
Figure 1.The outcomes of survival between hyperthermia group and non-hyperthermia group. (A) 1-year OS rates between two groups (P<0.05). (B) 1-year PFSfirst rates between two groups (P<0.01).